OmniActive’s OmniLean Obtains Self-Affirmed Gras Notification

OmniActive’s OmniLean obtains self-affirmed GRAS notification

OmniActive’s OmniLean salacia extract has received self-affirmed GRAS (Generally Recognised as Safe) notification by an expert panel who evaluated the ingredient in accordance with stringent US Food and Drug Administration (FDA) safety criteria.

“OmniLean is a novel, differentiated ingredient with huge opportunity derived from its formula flexibility and versatility in the metabolic health, weight management and satiety categories,” said Lynda M. Doyle, Sr VP of Global Marketing, OmniActive.


Read More on Neutraceutical Business Review